$CVKD Announces End-of-Phase 2 Meeting with the FDA and

New Post Public Reply Private Reply Replies (0) Message Board Keep
Golden Cross
16
$CVKD Announces End-of-Phase 2 Meeting with the FDA and Pivotal Phase 3 Registration Path for CAD-1005 in Heparin-Induced Thrombocytopenia (HIT)
https://www.stocktitan.net/news/CVKD/cadrenal...vc9he.html